$MDWK
Mdwerks Inc

2023 Q1 Form 10-K Financial Statement

#000149315223009080 Filed on March 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $41.45K $78.42K
YoY Change 655.01% 3599.06%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $41.45K $78.42K $136.7K
YoY Change 655.03% 3599.06% 557.31%
Operating Profit -$41.45K -$136.7K
YoY Change 654.48% 557.38%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$41.45K -$78.42K
YoY Change 655.01% 776.2%
Income Tax
% Of Pretax Income
Net Earnings -$41.45K -$78.42K -$136.7K
YoY Change 655.03% 776.2% -459.98%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 123.3M shares 18.01M shares 24.57M shares
Diluted Shares Outstanding 122.7M shares 24.57M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $41.23K $23.72K $23.72K
YoY Change
Cash & Equivalents $41.23K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $41.23K $23.72K $23.72K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets -$2.00 -$23.72K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $41.23K $23.72K $23.72K
Total Long-Term Assets -$2.00 -$23.72K $0.00
Total Assets $41.23K $23.72K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.18K $34.48K $138.7K
YoY Change -16.87% 2927.04% 605.39%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $112.1K $128.1K $138.7K
YoY Change -52.58% -44.51% -39.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $112.1K $128.1K $138.7K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $112.0K $128.1K $138.7K
YoY Change -52.58% -44.51% -39.91%
SHAREHOLDERS EQUITY
Retained Earnings -$489.2K -$430.7K
YoY Change 46.5%
Common Stock $123.4K $122.3K
YoY Change 578.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$70.82K -$128.1K -$115.0K
YoY Change
Total Liabilities & Shareholders Equity $41.23K $23.72K
YoY Change

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$41.45K -$78.42K -$136.7K
YoY Change 655.03% 776.2% -459.98%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities -$58.75K -$54.55K -$114.0K
YoY Change 5775.4% 5095.24% 479.8%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $76.27K 54.55K $114.0K
YoY Change 7526.7% 5095.24% 479.8%
NET CHANGE
Cash From Operating Activities -$58.75K -54.55K -$114.0K
Cash From Investing Activities
Cash From Financing Activities $76.27K 54.55K $114.0K
Net Change In Cash $17.51K 0.000 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$58.75K -$54.55K -$114.0K
Capital Expenditures
Free Cash Flow -$58.75K -$114.0K
YoY Change 5775.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001295514
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Assets
Assets
usd
CY2021Q4 us-gaap Assets
Assets
usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2022 us-gaap Interest Expense
InterestExpense
usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2022 MDWK Imputed Interest
ImputedInterest
usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 MDWK Noncash Investing Forgiveness Of Debt As Capital Contribution Related Party
NoncashInvestingForgivenessOfDebtAsCapitalContributionRelatedParty
usd
CY2021 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-56299
CY2022 dei Entity Registrant Name
EntityRegistrantName
MDwerks, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-1095411
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
411 Walnut Street
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 20125
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Green Cove Springs
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32043
CY2022 dei City Area Code
CityAreaCode
(252)
CY2022 dei Local Phone Number
LocalPhoneNumber
501-0019
CY2022 dei Security12b Title
Security12bTitle
Common
CY2022 dei Trading Symbol
TradingSymbol
MDWK
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
261956 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
123273097 shares
CY2021 dei Auditor Firm
AuditorFirmId
5854
CY2022 dei Auditor Firm
AuditorFirmId
2738
CY2021 dei Auditor Name
AuditorName
TAAD LLP
CY2021 dei Auditor Location
AuditorLocation
Diamond Bar, CA
CY2022 dei Auditor Name
AuditorName
M&K CPAS, PLLC
CY2022 dei Auditor Location
AuditorLocation
Houston, TX
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
23871 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1139 usd
CY2022Q4 MDWK Advances Payable Current
AdvancesPayableCurrent
104204 usd
CY2021Q4 MDWK Advances Payable Current
AdvancesPayableCurrent
19659 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
210000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
128075 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
230798 usd
CY2022Q4 us-gaap Liabilities
Liabilities
128075 usd
CY2021Q4 us-gaap Liabilities
Liabilities
230798 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
8957500 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
8957500 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
8958 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
122260208 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
122260208 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18010028 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18010028 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
122260 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
18010 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
171431 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
35195 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-430724 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-294003 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-128075 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-230798 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
136721 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20798 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
136721 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
20798 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-136721 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-20798 usd
CY2021 us-gaap Interest Expense
InterestExpense
6825 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
65599 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
58774 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-136721 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
37976 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24565003 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18010208 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24565003 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18010208 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-275599 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
6825 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
37976 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-230798 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-230798 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-136721 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-136721 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
239444 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-128075 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-136721 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
37976 usd
CY2021 MDWK Imputed Interest
ImputedInterest
6825 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
22732 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-64460 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-113989 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19659 usd
CY2022 MDWK Proceeds From Advances
ProceedsFromAdvances
113989 usd
CY2021 MDWK Proceeds From Advances
ProceedsFromAdvances
19659 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
113989 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19659 usd
CY2022 MDWK Noncash Investing Forgiveness Of Debt As Capital Contribution Related Party
NoncashInvestingForgivenessOfDebtAsCapitalContributionRelatedParty
239444 usd
CY2022 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
104250 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_z4WypxcdYEX4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zTVJF3uWAHUk">Use of Estimates and Assumptions</span> – </b>The preparation of financial statements in accordance with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results can, and in many cases will, differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-136721 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-430724 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
23871 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1139 usd
CY2022Q3 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
239444 usd
CY2014Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
210000 usd
CY2014Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
210000 usd
CY2014Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0005
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.0999 pure
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
210000 usd
CY2022Q3 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
239444 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
122260208 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
122260208 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
8957500 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
8957500 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2022Q3 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
239444 usd

Files In Submission

Name View Source Status
0001493152-23-009080-index-headers.html Edgar Link pending
0001493152-23-009080-index.html Edgar Link pending
0001493152-23-009080.txt Edgar Link pending
0001493152-23-009080-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
logo_001.jpg Edgar Link pending
mdwk-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mdwk-20221231_cal.xml Edgar Link unprocessable
mdwk-20221231_def.xml Edgar Link unprocessable
mdwk-20221231_lab.xml Edgar Link unprocessable
mdwk-20221231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed